Startup Dossier
StemInov
Biopharmaceutical company pioneering mesenchymal stem cell-based therapies for severe inflammatory and autoimmune diseases, with a lead candidate WhartSep® targeting complications from severe pneumonia.
active
Typestartup
SectorBioTech
LocationIllkirch
About
Biopharmaceutical company pioneering mesenchymal stem cell-based therapies for severe inflammatory and autoimmune diseases, with a lead candidate WhartSep® targeting complications from severe pneumonia.
Structural DNA
Legal Name
StemInov
SIREN
845327352
Founders & Team
Funding Lineage
Series A
Angels Santé (Lead)
€10.6M
Sept 2025
Programs
i-Lab
2019Pharmacie & biotechnologies